Dermapharm Holding SE (XTER:DMP) Net Issuance of Debt : €-101 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Dermapharm Holding SE's net issuance of debt for the three months ended in Dec. 2024 was €-53 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2024 was €-101 Mil.

Dermapharm Holding SE Net Issuance of Debt Historical Data

The historical data trend for Dermapharm Holding SE's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE Net Issuance of Debt Chart

Dermapharm Holding SE Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Debt

Get a 7-Day Free Trial

56.16

-21.50

-66.98

300.80

-101.41

Dermapharm Holding SE Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Issuance of Debt	Get a 7-Day Free Trial															-17.86	-45.88	43.01	-45.40	-53.13

Dermapharm Holding SE Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-101 Mil.

Dermapharm Holding SE Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (XTER:DMP) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

DMPHF:USA 0A5J:UK DMPd:UK

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.com

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.

Executives

Wilhelm Beier	Supervisory Board
Dr. Hans-georg Feldmeier	Board of Directors
Christof Dreibholz	Board of Directors
Lothar Lanz	Supervisory Board
Anja Schorn	Board Member Themis Beteiligungs-AG
Hilde Neumeyer	Board of Directors

Dermapharm Holding SE Headlines

No Headlines